Moderate riskFDA DrugClass II

Asteria Health testosterone pellets recalled for potential metal particulate contamination

Asteria Health testosterone pellets (62.5 mg) may contain metal particulate matter. The affected lot (251000125, expiring 06/02/2026) was distributed nationwide. About 1,758 pellets are involved in this recall.

From the FDA notice · Read the official notice ↗

What to do

  1. Stop using testosterone pellets from lot #251000125 immediately
  2. Contact your healthcare provider or pharmacist about next steps
  3. Do not use pellets from this lot even if they appear normal

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Testosterone, 62.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1062-32.
Sold in
Nationwide
Made for
Adults (0 months and older)

This recall covers 25 products — see all of them.

Details

Units affected
1,758 pellets.
Illnesses reported
None reported
Manufactured in
432 Industrial Ln, N/A, Birmingham, AL, United States
Classification
Class II
Recall number
D-0321-2026

In the FDA's words

Description
Testosterone, 62.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1062-32. Presence of Foreign substance - potential presence of metal particulate matter Lot#: 251000125, Exp. 06/02/2026. Distribution: Nationwide in the USA Affected quantity: 1,758 pellets.
Hazard
Presence of Foreign substance - potential presence of metal particulate matter

25 products in this recall

Asteria Health estradiol and testosterone pellets recalled for metal risk

Asteria Health is recalling 25 sterile pellet products, all sold under the Asteria Health name, for possible metal particles. The products are estradiol and testosterone pellets, including some that also contain anastrozole or triamcinolone acetonide. No injuries have been reported.

The agency lists each product separately. Check every one you might have.

Related topics

MetalParticulateDrugsSold nationwideMore from FDA Drug